Black Pearl Equities Proposes All-Cash Acquisition of Selectis Health at $4.00 Per Share
New York, Monday, 9 February 2026.
Black Pearl initiates a strategic move to acquire Selectis, offering shareholders $4.00 per share in an all-cash deal that promises an immediate change in corporate control.
Tender Offer Structure and Valuation
On February 9, 2026, Black Pearl Equities, LLC formally announced its intent to acquire all outstanding common stock of Selectis Health, Inc. [1]. The proposed transaction is structured as a third-party tender offer, valuing the target company’s shares at $4.00 per share [2]. This valuation is to be paid entirely in cash, net to the seller, without interest, and subject to any necessary tax withholding [2]. While the public announcement occurred on February 9, preliminary communications regarding the offer were filed with the U.S. Securities and Exchange Commission (SEC) on February 6, 2026, via a Schedule TO-C [2].
Regulatory Requirements and Timeline
Despite the announcement, the tender offer has not yet officially commenced [1]. Before the acquisition can proceed, Black Pearl Equities is required to file a Tender Offer Statement on Schedule TO with the SEC [1][2]. Following this, Selectis Health will be obligated to file a Solicitation/Recommendation Statement on Schedule 14D-9, which will formally advise shareholders on whether to accept or reject the bid [1][2]. As of the filing date on February 6, 2026, the documents submitted serve strictly informational purposes and do not constitute a finalized solicitation to sell shares [2].
Corporate Leadership and Next Steps
The acquisition effort is being spearheaded by Abraham Schwartz, President of Black Pearl Equities, who certified the accuracy of the preliminary tender offer statement [2]. The firm, based in Brooklyn, New York, has indicated that it does not intend to update forward-looking statements regarding the transaction unless required by law [1][2]. Shareholders and market observers are now awaiting the formal filing of the Schedule TO to determine the precise commencement date of the offer period [1].